tiprankstipranks
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
US Market
Want to see SNSE full AI Analyst Report?

Sensei Biotherapeutics (SNSE) Income Statement

234 Followers

Sensei Biotherapeutics Income Statement

Last quarter (Q4 2025), Sensei Biotherapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Sensei Biotherapeutics's net income was $-4.72M. See Sensei Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -551.00K$ -571.00K$ -1.81M$ -685.00K
Operating Expenses
$ 22.29M$ 31.11M$ 36.49M$ 47.31M$ 36.80M
Depreciation and Amortization
$ 139.00K$ 551.00K$ 3.68M$ 1.81M$ 685.00K
EBITDA
$ -20.91M$ -29.52M$ -33.39M$ -46.56M$ -35.44M
Operating Income
$ -22.29M$ -31.66M$ -37.06M$ -49.12M$ -37.48M
Other Income/Expenses
$ 1.20M$ 1.51M$ 2.96M$ 532.00K$ 688.00K
Pretax Income
$ -21.09M$ -30.16M$ -34.10M$ -48.59M$ -36.79M
Net Income
$ -21.09M$ -30.16M$ -34.10M$ -48.59M$ -36.79M
Per Share Metrics
Basic EPS
$ -16.72$ -1.20$ -1.22$ -1.58$ -1.33
Diluted EPS
$ -16.72$ -1.20$ -1.22$ -1.58$ -1.33
Weighted Average Shares Outstanding
1.26M 25.12M 27.95M 30.70M 27.71M
Weighted Average Shares Outstanding (Diluted)
1.26M 25.12M 27.95M 30.70M 27.71M
Currency in USD

Sensei Biotherapeutics Earnings and Revenue History